Maybe Linus Pauling was on to something after all. Decades ago the Nobel Prize\u2013winning chemist was relegated to the fringes of medicine after championing the idea that vitamin C could combat a host of illnesses, including cancer. Now, a study published online today in\u00a0Science\u00a0reports that vitamin C can kill tumor cells that carry a common cancer-causing mutation and\u2014in mice\u2014can curb the growth of tumors with the mutation.If the findings hold up in people, researchers may have found a way to treat a large swath of tumors that has lacked effective drugs. "This [could] be one answer to the question everybody's striving for," says molecular biologist Channing Der of the University of North Carolina, Chapel Hill, one of\u00a0many researchers trying to target cancers with the mutation. The study is also gratifying for the handful of researchers pursuing vitamin C, or ascorbic acid, as a cancer drug. "I'm encouraged. Maybe people will finally pay attention," says vitamin C researcher Mark Levine of the National Institute of Diabetes and Digestive and Kidney Diseases.<\/p>\n","protected":false},"author":0,"featured_media":0,"template":"","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-1368511","news","type-news","status-publish","hentry"],"acf":[],"yoast_head":"\n